Drug intelligence / Profile preview

NGN-9076

Development stage
Unknown
Lead developer
NeuroGeneration
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intracerebral
01

Overview

NGN-9076 is an investigational cell therapy consisting of differentiated neurons derived from adult central nervous system progenitor (neural stem) cells, being developed by NeuroGeneration as a restorative treatment for Parkinson’s disease. The product is intended to replace or supplement degenerating nigrostriatal neurons by transplanting neural stem cell-derived neurons into targeted brain regions, with the goal of improving motor function and modifying disease progression rather than only providing symptomatic relief.[3][5] It is being evaluated in clinical studies of neural stem cell-derived neuron transplantation for Parkinson’s disease.[3][9][5]

Other names
intracerebral microinjections-NeuroGeneration-Parkinson's diseaseNeural Stem Cell-derived NeuronsAdult CNS Progenitor-derived NeuronsNeural Stem Cell Transplantation

Beyond the preview

Go deeper on NGN-9076.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NGN-9076.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call